RICHARD CHRISTOPHER
CIK 1271244 · Chief Executive Officer · last filed 2025-07-30
RICHARD CHRISTOPHER is a Chief Executive Officer who has filed 33 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing shows the insider bought $13.6K of LEXXW on Jul 30, 2025. Across all open-market trades the lifetime net is −$120.7K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
33
-$120.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Lexaria Bioscience Corp. (LEXXW) Delisted | Chief Executive Officer | 50,000 | $0.00 | $60 | $132.0K | 3 | 2025-07-30 |
| INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) Delisted | Chief Financial Officer | 5,220 | $0.32 | $1.7K | $0 | 5 | 2022-11-21 |
| ICAD INC (ICAD) Delisted | Executive VP and CFO | 117,854 | $3.87 | $456.1K | $0 | 7 | 2018-12-27 |
| DUSA | VP Finance & CFO | 0 | $56.18 | $0 | -$252.8K | 18 | 2012-12-20 |
Recent Filings
33 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-30 | Lexaria Bioscience Corp. (LEXXW) Delisted | Buy (P) | +15,000 | $13.6K | EDGAR |
| 2025-05-16 | Lexaria Bioscience Corp. (LEXXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-12-03 | Lexaria Bioscience Corp. (LEXXW) Delisted | Buy (P) | +50,000 | $118.4K | EDGAR |
| 2022-11-21 | INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-22 | INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-12 | INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) Delisted | Buy (P) | +3,636 | $0 | EDGAR |
| 2019-09-27 | INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) Delisted | Grant (A) | +47,500 | $0 | EDGAR |
| 2019-01-16 | INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-12-27 | ICAD INC (ICAD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-12-06 | ICAD INC (ICAD) Delisted | Tax (F) | −4,909 | -$20.0K | EDGAR |